Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
DSMB support in continuing the Phase 3 clinical trial; No serious adverse events and safety concerns reported to date.Phase 3...
DSMB support in continuing the Phase 3 clinical trial; No serious adverse events and safety concerns reported to date.Phase 3...
Accomplished leader in laboratory innovations and diagnostics Pascal Bamford, PhD Pascal Bamford, PhD, SVP, R&D and Laboratory Operations, Akoya Biosciences...
TUSTIN, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO)...
Conference Call and Live Audio Webcast Scheduled for Thursday, November 4, 2021, 5:00 p.m. ETHOUSTON, Oct. 26, 2021 (GLOBE NEWSWIRE)...
Glytec named sole supplier of insulin management software for Premier’s network of more than 4,400 U.S. hospitals and 225,000 providers...
Florida-based healthcare institution leverages eClinicalWorks’ cloud EHR to boost clinical outcomes and simplify workflows WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, a leader in...
PORTLAND, Maine--(BUSINESS WIRE)--$CVET #earnings--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release...
Mr. Sambasivan will build on the success of CitiusTech as a leader in healthcare digital transformation, and drive scalability and...
Augury’s machine health technology will further build out Baker Hughes’ integrated asset performance capability, expanding coverage from critical assets to...
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
Savings could be passed on to patients to improve affordability and access NEW YORK--(BUSINESS WIRE)--A new report from Accenture (NYSE:...
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
9M 2021 REVENUES EXPECTED TO BE IN THE RANGE OF € 425 - 435 MADJUSTED 9M 2021 EBITDA EXPECTED TO...
MEDIA INFORMATIONXlife Sciences AG (XLS DE): Partnership with Vision 2030Xlife Sciences AG is elected as Innovation Partner for Saudi ArabiaXlife...